New Indication for Weight Loss Drug Semaglutide

被引：0
|
作者：
Aschenbrenner, Diane S. [1 ,2 ]
机构：
[1] Notre Dame Maryland Univ, Baltimore, MD 21210 USA
[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA
来源：
AMERICAN JOURNAL OF NURSING | 2023年 / 123卷 / 06期
关键词：
D O I：
10.1097/01.NAJ.0000938724.36679.23
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
The weight loss drug semaglutide (Wegovy) is now approved for pediatric patients ages 12 and older whose body mass index categorizes them as obese.
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] A Renal Indication for Semaglutide (Ozempic)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2025, 67 (1723):
  • [32] Semaglutide for Weight Loss: Was It Worth the Weight? (vol 30, pg 324, 2022)
    Novograd
    Mullally, Jamie
    CARDIOLOGY IN REVIEW, 2023, 31 (01) : 57 - 57
  • [33] Weight Loss as Indication for FDG PET/CT
    Maliha, Peter George
    Singerman, Julia
    Probst, Stephan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [34] Glycaemic control and weight loss with semaglutide in type 2 diabetes
    Madsbad, Sten
    Holst, Jens J.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 315 - +
  • [35] EHR Data Suggest Tirzepatide Outdoes Semaglutide for Weight Loss
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (08):
  • [36] Adiposity and Vascular Aging Indication for Weight Loss?
    Nilsson, Peter M.
    HYPERTENSION, 2015, 66 (02) : 270 - 272
  • [37] Neoadjuvant Semaglutide, Bariatric Surgery Weight Loss, and Overall Outcomes
    Mathur, Vasundhara
    Wasden, Katherine
    Shin, Thomas H.
    Medhati, Pourya
    Nimeri, Abdelrahman A.
    Tavakkoli, Ali
    Sheu, Eric G.
    JAMA SURGERY, 2025,
  • [38] Weight loss associated with semaglutide treatment among people with HIV
    Haidar, Lara
    Crane, Heidi M.
    Nance, Robin M.
    Webel, Allison
    Ruderman, Stephanie A.
    Whitney, Bridget M.
    Willig, Amanda L.
    Napravnik, Sonia
    Mixson, L. Sarah
    Leong, Christine
    Lavu, Alekhya
    Aboulatta, Laila
    Dai, Mindy
    Hahn, Andrew
    Saag, Michael S.
    Bamford, Laura
    Cachay, Edward
    Kitahata, Mari M.
    Mayer, Kenneth H.
    Jacobson, Jeffrey
    Moore, Richard D.
    Delaney, Joseph A. C.
    Drumright, Lydia N.
    Eltonsy, Sherif
    AIDS, 2024, 38 (04) : 531 - 535
  • [39] Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
    Rodriguez, Patricia J.
    Goodwin Cartwright, Brianna M.
    Gratzl, Samuel
    Brar, Rajdeep
    Baker, Charlotte
    Gluckman, Ty J.
    Stucky, Nicholas L.
    JAMA INTERNAL MEDICINE, 2024, 184 (09) : 1056 - 1064
  • [40] Semaglutide versus Liraglutide for higher Weight Loss in overweight Patients
    Rubino, D. M.
    AKTUELLE ERNAHRUNGSMEDIZIN, 2022, 47 (03): : 165 - 165
12345